INSULIN-LIKE GROWTH FACTOR-1, CYTOLYSIS AND CHOLESTASIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS

INSULIN-LIKE GROWTH FACTOR-1, CYTOLYSIS AND CHOLESTASIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS

Show other versions (1)

<p><strong>Purpose.</strong> The study was designed to assess the relationship between the level of plasma concentration of insulin-like growth factor-1 (IGF-1) and indices of the functional state of the liver in patients with non-alcoholic fatty liver disease (NAFLD) and its combi...

Full description

Bibliographic Details
Main Authors:	L. V. Zhuravlyova, E. V. Ogneva
Format:	Article
Language:	Russian
Published:	ABV-press 2014-07-01
Series:	Klinicist
Subjects:	non-alcoholic fatty liver disease type 2 diabetes mellitus obesity insulin-like growth factor-1
Online Access:	http://klinitsist.abvpress.ru/index.php/Klin/article/view/10

Similar Items

INSULIN-LIKE GROWTH FACTOR-1, CYTOLYSIS AND CHOLESTASIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS
by: L. V. Zhuravlyova, et al.
Published: (2014-07-01)

Insulin‐like growth factor‐1 is inversely associated with liver fibrotic markers in patients with type 2 diabetes mellitus
by: Shozo Miyauchi, et al.
Published: (2019-07-01)

Chronic Alcohol Consumption is Inversely Associated with Insulin Resistance and Fatty Liver in Japanese Males
by: Takemi Akahane, et al.
Published: (2020-04-01)

NON-ALCOHOLIC FATTY LIVER DISEASE AND SARCOPENIA
by: Pivtorak K. V., et al.
Published: (2022-11-01)

Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues
by: Wan Mu, et al.
Published: (2019-01-01)

Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review
by: D Shyangdan, et al.
Published: (2011-11-01)

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the problem of conjunction and phasing
by: E. V. Kiseleva, et al.
Published: (2021-10-01)

The Frequency of Non-Alcoholic Fatty Liver Disease in Adults with Diabetes Mellitus
by: Raheel Akhtar Yousafzai, et al.
Published: (2023-08-01)

Patient Management in Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
by: A. E. Bagriy, et al.
Published: (2021-06-01)

Alcoholism and Diabetes Mellitus
by: Soo-Jeong Kim, et al.
Published: (2012-04-01)

Association of insulin resistance and non-alcoholic fatty liver disease
by: Ekaterina E. Mishina, et al.
Published: (2021-01-01)

Intrahepatic cholestasis in nonalcoholic fatty liver disease
by: A A Shipovskaya, et al.
Published: (2018-02-01)

Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver
by: Jiayin Yao, et al.
Published: (2013-01-01)

Lipid profile, insulin resistance & non-alcoholic fatty liver disease (NAFLD) among type 2 diabetes patients getting treatment in Jaffna
by: Sittampalam Rajendra, et al.
Published: (2024-06-01)

INSULIN AND INSULIN RECEPTOR GENE POLYMORPHISMS AND SUSCEPTIBILITY TO NONALCOHOLIC FATTY LIVER DISEASE
by: Hossein NOBAKHT, et al.
Published: (2020-07-01)

Influence of Hyperhomocysteinemia on Development of Non-Alcoholic Fatty Liver Disease in Diabetes Mellitus
by: A.V. Vlasenko
Published: (2013-02-01)

Neck Circumference as a Predictor of Insulin Resistance in People with Non-alcoholic Fatty Liver Disease
by: Da-Hye Son, et al.
Published: (2023-09-01)

Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
by: Hye Won Lee
Published: (2023-01-01)

Association of Non-Alcoholic Fatty Liver Dis-ease and Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study
by: Zahra Heidari, et al.
Published: (2022-03-01)

Intrahepatic Cholestasis in Non-Alcoholic Fatty Liver Disease: Pathogenesis and Role of Ademetionine in Treatment
by: Ye. N. Shirokova
Published: (2023-08-01)

The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease
by: Moon Young Kim
Published: (2017-06-01)

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: general approaches to the choice of therapy
by: Nina A. Petunina, et al.
Published: (2022-11-01)

Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
by: Jun-Hyuk Lee, et al.
Published: (2023-01-01)

Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
by: Satoko Ohmi, et al.
Published: (2017-09-01)

Comparison of aspartate aminotransferase platelet ratio index score and insulin resistance in type 2 diabetes mellitus with non-alcoholic fatty liver disease
by: Gupta Nikhil, et al.
Published: (2023-01-01)

Serum interleukin-38 levels correlated with insulin resistance, liver injury and lipids in non-alcoholic fatty liver disease
by: Jun Cao, et al.
Published: (2022-08-01)

Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics
by: A. V. Anisonyan, et al.
Published: (2020-09-01)

Impact of insulin resistance on mild cognitive impairment in type 2 diabetes mellitus patients with non-alcoholic fatty liver disease
by: Hui Zhang, et al.
Published: (2023-11-01)

Hepatocyte Toll-Like Receptor 4 Mediates Alcohol-Induced Insulin Resistance in Mice
by: Piumi B. Wickramasinghe, et al.
Published: (2023-03-01)

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota
by: Fan Du, et al.
Published: (2021-02-01)

Glucagon like Peptide-1(GLP-1) a Novel Therapeutic Strategy in Non-Alcoholic Fatty Liver Disease (NAFLD)
by: Ebrahim Abbasi Oshaghi
Published: (2017-12-01)

METABOLIC TANDEM TARGETS: NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS
by: L. A. Zvenigorodskaya, et al.
Published: (2018-01-01)

Endoplasmic reticulum stress PERK-ATF4-CHOP pathway is involved in non-alcoholic fatty liver disease in type 1 diabetic rats: The rescue effect of treatment exercise and insulin-like growth factor I
by: Shadi Mohammadpour-Asl, et al.
Published: (2024-03-01)

Metabolic Score for Insulin Resistance Is Inversely Related to Incident Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
by: Jun-Hyuk Lee, et al.
Published: (2022-07-01)

Osteoporosis risk prediction in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease
by: Yu. A. Titova, et al.
Published: (2020-10-01)

Circulating Short-Chain Fatty Acids and Non-Alcoholic Fatty Liver Disease Severity in Patients with Type 2 Diabetes Mellitus
by: Hui-Ju Tsai, et al.
Published: (2023-03-01)

The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population
by: Behnam Rabiee, et al.
Published: (2017-04-01)

Diabetes Mellitus among Patients with Non-alcoholic Fatty Liver Disease Visiting the Outpatient Department of Internal Medicine in a Tertiary Care Centre
by: Prabin Adhikari, et al.
Published: (2023-11-01)

Glucose intolerance and insulin resistance in non-alcoholic fatty liver disease: A Hospital-based Cross-sectional Study from Southern Karnataka, India
by: Thomas Mathew, et al.
Published: (2017-01-01)

Associations between serum clusterin levels and non-alcoholic fatty liver disease
by: Yansu Wang, et al.
Published: (2023-06-01)